Brief: Adaptive Biotechnologies Corp - Adaptive's Work With Epic Will Commence Immediately, With Clonoseq Integration Expected To Go Live In 2023
11/10/2022 13:10
Oct 11 (Reuters) - Adaptive Biotechnologies Corp
ADPT.O :
* ADAPTIVE ANNOUNCES PARTNERSHIP WITH EPIC TO INCREASE
ACCESS TO
MINIMAL RESIDUAL DISEASE (MRD) MONITORING IN BLOOD CANCERS
* ADAPTIVE BIOTECHNOLOGIES CORP - ADAPTIVE'S WORK WITH EPIC
WILL
COMMENCE IMMEDIATELY, WITH CLONOSEQ INTEGRATION EXPECTED TO GO
LIVE IN 2023
Source text for Eikon: ID:nGNX65kh8z
Further company coverage: ADPT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adaptive Biotechnologies
See all newsBrief: Adaptive Biotechnologies Corp - Issues $345 Million In 0% Convertible Senior Notes Due 2031 - SEC Filing
U.S. STOCKS ON THE MOVE-Jabil, BWX Technologies, Micron
U.S. STOCKS ON THE MOVE-Jabil, BWX Technologies, Micron
U.S. STOCKS ON THE MOVE-Intel, La-Z-Boy, CME
U.S. STOCKS ON THE MOVE-Intel, La-Z-Boy, AST SpaceMobile